p53-Dependent and independent expression of p21 during cell growth, differentiation, and DNA damage

Genes and Development

Volumn 9, Issue 8, 1995, Pages 935-944

  Macleod, Kay F ^a   Sherry, Nicole ^a   Hannon, Greg ^a   Beach, David ^a   Tokino, Takashi ^b   Kinzler, Kenneth ^b   Vogelstein, Bert ^b   Jacks, Tyler ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

cellular differentiation; DNA damage; p21; p53

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; CYCLIN DEPENDENT KINASE; CYCLOHEXIMIDE; DIMETHYL SULFOXIDE; DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEXAMETHYLENEBISACETAMIDE; HISTONE H1; MESSENGER RNA; METHIONINE; PROTAMINE KINASE; PROTEIN P21; PROTEIN P53;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; ERYTHROLEUKEMIA CELL; FIBROBLAST; GAMMA IRRADIATION; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SERUM; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR GENE;

ANIMALIA; MURINAE;

EID: 0028963841     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.9.8.935     Document Type: Article

References (39)

1. Ben-David, Y. and A. Bernstein. 1991. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell 66: 831-834.
2. 1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes & Dev. 8: 2540-2551.
3. Donehower, L.A., M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery Jr., J.S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
4. El-Diery, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
5. El-Deiry, W., J.W. Harper, P.M. O'Connor, V.E. Velculescu, C.E. Canman, J. Jackman, J.A. Pietenpol, M. Burrell, D.E. Hill, Y. Wang, K.G. Wiman, W.E. Mercer, M.B. Kastan, K.W. Kohn, S.J. Elledge, K.W. Kinzler, and B. Vogelstein. 1994. WAF1/ CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54: 1169-1174.
6. Gorman, C.M., L.F. Moffat, and B.H. Howard. 1982. Recombinant genomes which express CAT in mammalian cells. Mol. Cell. Biol. 2: 1044-1051.
7. Halevny, O., B.G. Novitch, D.T. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (in press).
8. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257-261.
9. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
10. Hill, C.S., R. Marais, S. John, J. Wynne, S. Dalton, and R. Treisman. 1993. Functional analysis of a growth factor-responsive transcription factor complex. Cell 73: 395-406.
11. Hussussian, C.J., J.P. Struewing, A.M. Goldstein, P.A.T. Higgins, D.S. Ally, M.D. Sheahan, W.H. Clark Jr., M.A. Tucker, and N. Dracopli. 1994. Germline p16 mutations in familial melanoma. Nature Genet. 8: 15-21.
12. Jacks, T., L. Remington, B. Williams, E.M. Schmitt, S. Halachni, R.T. Bronson, and R.A. Weinberg. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4: 1-7.
13. Jiang, H., J. Lin, Z. Su, F.R. Collart, E. Huberman, and P.B. Fisher. 1994. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF-1/CIP1, expression in the absence of p53. Oncogene 9: 3397-3406.
14. Kamb, A., N.A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S.V. Tavtigian, E. Stockert, R.S. Day III, B.E. Johnson, and M.H. Skolnick. 1994a. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440.
15. Kamb, A., D. Shattuck-Eidens, R. Eeles, Q. Liu, N.A. Gruis, W. Ding, C. Hussey, T. Tran, Y. Miki, J. Weaver-Feldhaus, M. McClure, J.F. Aitken, D.E. Anderson, W. Bergman, R. Frants, D.E. Goldgar, A. Green, R. MacLennan, N.G. Martin, L.J. Meyer, P. Youl, J.J. Zone, M.H. Skolnick, and L.A. Cannon-Albright. 1994b. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet. 8: 22-26.
16. Kiyokawa, H., V.M. Richon, G. Venta-Perez, R.A. Rifkind, and P.A. Marks. 1993. Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1. Proc. Natl. Acad. Sci. 90: 6746-6750.
17. Li, R., S. Waga, G.J. Hannon, D. Beach, and B. Stillman. 1994. Differential effects by the p21 cdk inhibitor on PCNA-dependent DNA replication and repair. Nature 371: 534-537.
18. Marais, R., J. Wynne, and R. Treisman. 1993. The SRF accessory protein Elk-1 contains a growth factor regulated transcriptional activation domain. Cell 73: 381-393.
19. Marks, P.A. and R.A. Rifkind. 1978. Erythroleukemic differentiation. Annu. Rev. Biochem. 47: 419-448.
20. Merrit, A.J., C.S. Potten, C.S. Kemp, J.A. Hickman, A. Balmain, D.P. Lane, and P.A. Hall. 1994. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res. 54: 614-617.
21. Michieli, P., M. Chedid, D. Lin, J.H. Pierce, W.E. Mercer, and D. Givol. 1994. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54: 3391-3395.
22. Mowat, M., A. Cheng, N. Kimura, A. Bernstein, and S. Benchimol. 1985. Rearrangements of the cellular p53 gene in erythroleukemic cells transformed by Friend virus. Nature 314: 633-636.
23. Munroe, D.G., J.W. Peacock, and S. Benchimol. 1990. Inactivation of the cellular p53 gene is a common feature of Friend virus induced erythroleukemia: Relationship of inactivation to dominant transforming alleles. Mol. Cell. Biol. 10: 3307-3313.
24. Nobori, T., K. Miura, D.J. Wu, A. Lois, K. Takabayashi, and D.A. Carson. 1994. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756.
25. Noda, A., Y. Ning, S. Venable, O.M. Pereira-Smith, and J.R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211: 90-98.
26. Penn, L.J.Z., M.W. Brooks, E.M. Laufer, and H. Land. 1990. Negative autoregulation of c-myc transcription. EMBO J. 9: 1113-1121.
27. Pietenpol, J.A., T. Tokino, S. Thiagalingam, W. El-Deiry, K. Kinzler, and B. Vogelstein. 1994. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. 91: 1998-2002.
28. Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell-cycle arrest. Genes & Dev. 8: 9-22.
29. Prosser, H.M., D. Wotton, A. Gegonne, J. Ghysdael, S. Wang, N.A. Speck, and M.J. Owen. 1992. A phorbal ester response element within the human T-cell receptor β-chain enhancer. Proc. Natl. Acad. Sci. 89: 9934-9938.
30. Richon, V., R.A. Rifkind, and P.A. Marks. 1992. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells. Cell Growth Differ. 3: 413-420.
31. Robertson, E.J. 1987. Teratocarcinomas and embryonic stem cells. IRL Press, Oxford, UK.
32. Sassone-Corsi, P., J.C. Sisson, and I.M. Verma. 1988. Transcriptional autoregulation of the proto-oncogene fos. Nature 334: 314-319.
33. Serrano, M., G.J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/cdk4. Nature 366: 704-708.
34. Shackleford, G.M. and H.E. Varmus. 1987. Expression of the proto-oncogene int-1 is restricted to postmeiotic male germ cells and the neural tube of mid-gestational embryos. Cell 50: 89-95.
35. Steinman, R.A., B. Hoffman, A. Iro, C. Guillouf, D.A. Lieberman, and M.E. El-Houseini. 1994. Induction of p21 (WAF-1/ CIP1) during differentiation. Oncogene 9: 3389-3396.
36. Waga, S., G.J. Hannon, D. Beach, and B. Stillman. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578.
37. Xiong, Y., H. Zhang, and D. Beach. 1993a. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes &. Dev. 7: 1572-1583.
38. Xiong, Y., G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993b. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
39. Zhang, H., G.J. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes & Dev. 8: 1750-1758.